{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:26:43Z","timestamp":1763605603400,"version":"3.45.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00666-2","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:21:57Z","timestamp":1763605317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IgG4 plasma cells in hematopathology: beyond IgG4-related disease"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-9841","authenticated-orcid":false,"given":"Vaclav","family":"Stejskal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Sagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Kamaradova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"666_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"key":"666_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"T Rispens","year":"2023","unstructured":"Rispens T, Huijbers MG (2023) The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol 23:763\u2013778. https:\/\/doi.org\/10.1038\/s41577-023-00871-z","journal-title":"Nat Rev Immunol"},{"key":"666_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7\u201319. https:\/\/doi.org\/10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"key":"666_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.semdp.2024.01.003","volume":"41","author":"W Cheuk","year":"2024","unstructured":"Cheuk W, Bledsoe JR (2024) IgG4-related lymphadenopathy. Semin Diagn Pathol 41:108\u2013115. https:\/\/doi.org\/10.1053\/j.semdp.2024.01.003","journal-title":"Semin Diagn Pathol"},{"key":"666_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/his.13787","volume":"74","author":"K Arora","year":"2019","unstructured":"Arora K, Rivera M, Ting DT, Deshpande V (2019) The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls. Histopathology 74:688\u2013698. https:\/\/doi.org\/10.1111\/his.13787","journal-title":"Histopathology"},{"key":"666_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/mrcr\/rxac065","volume":"7","author":"M Yoshida","year":"2023","unstructured":"Yoshida M, Mizushima I, Tsuge S et al (2023) Development of IgG4-related pancreatitis and kidney disease 7 years after the onset of undiagnosed lymphadenopathy: a case report. Mod Rheumatol Case Rep 7:192\u2013196. https:\/\/doi.org\/10.1093\/mrcr\/rxac065","journal-title":"Mod Rheumatol Case Rep"},{"key":"666_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.semdp.2017.11.006","volume":"35","author":"MR Wick","year":"2018","unstructured":"Wick MR, O\u2019Malley DP (2018) Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis. Semin Diagn Pathol 35:61\u201366. https:\/\/doi.org\/10.1053\/j.semdp.2017.11.006","journal-title":"Semin Diagn Pathol"},{"key":"666_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/PAS.0000000000001076","volume":"42","author":"Y-R Chen","year":"2018","unstructured":"Chen Y-R, Chen Y-J, Wang M-C et al (2018) A newly recognized histologic pattern of IgG4-related lymphadenopathy: expanding the morphologic spectrum. Am J Surg Pathol 42:977\u2013982. https:\/\/doi.org\/10.1097\/PAS.0000000000001076","journal-title":"Am J Surg Pathol"},{"key":"666_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/PAS.0000000000000206","volume":"38","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi M, Sato Y, Yasui H et al (2014) Epstein-Barr virus\u2013infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Am J Surg Pathol 38:946. https:\/\/doi.org\/10.1097\/PAS.0000000000000206","journal-title":"Am J Surg Pathol"},{"key":"666_CR10","first-page":"10153","volume":"10","author":"Z Pan","year":"2017","unstructured":"Pan Z, Zhou J (2017) IgG4-related lymphadenopathy: a potentially under- and over-diagnosed entity. Int J Clin Exp Pathol 10:10153\u201310166","journal-title":"Int J Clin Exp Pathol"},{"key":"666_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mpdhp.2013.01.005","volume":"19","author":"JA Ferry","year":"2013","unstructured":"Ferry JA (2013) IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets. Diagn Histopathol 19:128\u2013139. https:\/\/doi.org\/10.1016\/j.mpdhp.2013.01.005","journal-title":"Diagn Histopathol"},{"key":"666_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/PAS.0000000000002007","volume":"47","author":"Y-R Chen","year":"2023","unstructured":"Chen Y-R, Yu S-C, Wang R-C et al (2023) Lymph nodes with increased IgG4-positive plasma cells and patterns suspicious for IgG4-related disease. Am J Surg Pathol 47:387\u2013396. https:\/\/doi.org\/10.1097\/PAS.0000000000002007","journal-title":"Am J Surg Pathol"},{"key":"666_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1309\/AJCPX6VF6BGZVJGE","volume":"142","author":"LL Martinez","year":"2014","unstructured":"Martinez LL, Friedl\u00e4nder E, van der Laak JAWM, Hebeda KM (2014) Abundance of IgG4+ plasma cells in isolated reactive lymphadenopathy is no indication of IgG4-related disease. Am J Clin Pathol 142:459\u2013466. https:\/\/doi.org\/10.1309\/AJCPX6VF6BGZVJGE","journal-title":"Am J Clin Pathol"},{"key":"666_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.path.2023.01.002","volume":"16","author":"JR Bledsoe","year":"2023","unstructured":"Bledsoe JR (2023) Immunoglobulin G4-related disease, Llymphadenopathy, and lymphoma: histopathologic features and diagnostic approach. Surg Pathol Clin 16:177\u2013195. https:\/\/doi.org\/10.1016\/j.path.2023.01.002","journal-title":"Surg Pathol Clin"},{"key":"666_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PAS.0000000000001579","volume":"45","author":"JR Bledsoe","year":"2021","unstructured":"Bledsoe JR, Ferry JA, Neyaz A et al (2021) IgG4-related lymphadenopathy: a comparative study of 41 cases reveals distinctive histopathologic features. Am J Surg Pathol 45:178\u2013192. https:\/\/doi.org\/10.1097\/PAS.0000000000001579","journal-title":"Am J Surg Pathol"},{"key":"666_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.anndiagpath.2013.04.010","volume":"17","author":"T Uehara","year":"2013","unstructured":"Uehara T, Masumoto J, Yoshizawa A et al (2013) IgG4-related disease-like fibrosis as an indicator of IgG4-related lymphadenopathy. Ann Diagn Pathol 17:416\u2013420. https:\/\/doi.org\/10.1016\/j.anndiagpath.2013.04.010","journal-title":"Ann Diagn Pathol"},{"key":"666_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/his.12658","volume":"67","author":"AC Bateman","year":"2015","unstructured":"Bateman AC, Ashton-Key MR, Jogai S (2015) Lymph node granulomas in immunoglobulin G4-related disease. Histopathology 67:557\u2013561. https:\/\/doi.org\/10.1111\/his.12658","journal-title":"Histopathology"},{"key":"666_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12308-011-0117-5","volume":"4","author":"IN Siddiqi","year":"2011","unstructured":"Siddiqi IN, Brynes RK, Grimm K et al (2011) Perifollicular granulomatous inflammation in reactive lymph nodes: a possible morphologic marker for IgG4 plasmacytosis. J Hematopathol 4:207\u2013214. https:\/\/doi.org\/10.1007\/s12308-011-0117-5","journal-title":"J Hematopathol"},{"key":"666_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12308-024-00615-5","volume":"17","author":"JL Conant","year":"2024","unstructured":"Conant JL, Bullis SSM, Wilburn C (2024) Perifollicular concentric granulomas: a clue to IgG4-related lymphadenopathy. J Hematop 17:227\u2013230. https:\/\/doi.org\/10.1007\/s12308-024-00615-5","journal-title":"J Hematop"},{"key":"666_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1066896917708609","volume":"25","author":"S-C Yu","year":"2017","unstructured":"Yu S-C, Tang J-L (2017) Reactive follicular hyperplasia with perifollicular granulomas and increased IgG4-positive plasma cells. Int J Surg Pathol 25:698\u2013699. https:\/\/doi.org\/10.1177\/1066896917708609","journal-title":"Int J Surg Pathol"},{"key":"666_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12308-023-00565-4","volume":"16","author":"RM Whitehair","year":"2023","unstructured":"Whitehair RM, Aguilera NS, Pramoonjago P, Craig JW (2023) Increased IgG4+ plasma cells are common in excised lymph nodes from children and adolescents without IgG4-related disease. J Hematop 16:209\u2013216. https:\/\/doi.org\/10.1007\/s12308-023-00565-4","journal-title":"J Hematop"},{"key":"666_CR22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.humpath.2015.07.006","volume":"46","author":"S Hartmann","year":"2015","unstructured":"Hartmann S, Winkelmann R, Metcalf RA et al (2015) Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma. Hum Pathol 46:1655\u20131661. https:\/\/doi.org\/10.1016\/j.humpath.2015.07.006","journal-title":"Hum Pathol"},{"key":"666_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00428-018-2460-8","volume":"473","author":"K Kiil","year":"2018","unstructured":"Kiil K, Bein J, Schuhmacher B et al (2018) A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma. Virchows Arch 473:759\u2013764. https:\/\/doi.org\/10.1007\/s00428-018-2460-8","journal-title":"Virchows Arch"},{"key":"666_CR24","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.humpath.2013.06.006","volume":"44","author":"CS Tudor","year":"2013","unstructured":"Tudor CS, Distel LV, Eckhardt J et al (2013) B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction. Hum Pathol 44:2475\u20132486. https:\/\/doi.org\/10.1016\/j.humpath.2013.06.006","journal-title":"Hum Pathol"},{"key":"666_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.15703","volume":"184","author":"AR Gholiha","year":"2019","unstructured":"Gholiha AR, Hollander P, Hedstrom G et al (2019) High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms. Br J Haematol 184:192\u2013201. https:\/\/doi.org\/10.1111\/bjh.15703","journal-title":"Br J Haematol"},{"key":"666_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12308-023-00559-2","volume":"16","author":"B Guler","year":"2023","unstructured":"Guler B, Tekden BC, Cetin G et al (2023) The role of IgG4-positive plasma cell population in classic Hodgkin lymphoma. J Hematop 16:191\u2013197. https:\/\/doi.org\/10.1007\/s12308-023-00559-2","journal-title":"J Hematop"},{"key":"666_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12308-021-00451-x","volume":"14","author":"AY Bahar","year":"2021","unstructured":"Bahar AY, Ko\u00e7arslan S, K\u0131l\u0131n\u00e7 E (2021) Is there a relationship between the clinicopathological features of classic Hodgkin lymphoma subtypes and an increase in IgG4-positive plasma cells? J Hematopathol 14:109\u2013115. https:\/\/doi.org\/10.1007\/s12308-021-00451-x","journal-title":"J Hematopathol"},{"key":"666_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/his.13965","volume":"76","author":"V Nowak","year":"2020","unstructured":"Nowak V, Agaimy A, Kristiansen G, G\u00fctgemann I (2020) Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall. Histopathology 76:244\u2013250. https:\/\/doi.org\/10.1111\/his.13965","journal-title":"Histopathology"},{"key":"666_CR29","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J et al (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131:2877\u20132890. https:\/\/doi.org\/10.1182\/blood-2018-03-839753","journal-title":"Blood"},{"key":"666_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1309\/AJCPARC3YQ0KLIOA","volume":"139","author":"X Zhang","year":"2013","unstructured":"Zhang X, Hyjek E, Vardiman J (2013) A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol 139:622\u2013632. https:\/\/doi.org\/10.1309\/AJCPARC3YQ0KLIOA","journal-title":"Am J Clin Pathol"},{"key":"666_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/his.12274","volume":"64","author":"MP Menon","year":"2014","unstructured":"Menon MP, Evbuomwan MO, Rosai J et al (2014) A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology 64:455\u2013459. https:\/\/doi.org\/10.1111\/his.12274","journal-title":"Histopathology"},{"key":"666_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1309\/AJCPFH0SJ6YILXJU","volume":"140","author":"L Liu","year":"2013","unstructured":"Liu L, Perry AM, Cao W et al (2013) Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol 140:395\u2013402. https:\/\/doi.org\/10.1309\/AJCPFH0SJ6YILXJU","journal-title":"Am J Clin Pathol"},{"key":"666_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bjd.17939","volume":"181","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen H, Jiang YQ et al (2019) Clinicopathological features of cutaneous Rosai-Dorfman disease and its relationship to IgG4-related disease: a retrospective study. Br J Dermatol 181:844\u2013845. https:\/\/doi.org\/10.1111\/bjd.17939","journal-title":"Br J Dermatol"},{"key":"666_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.abd.2022.07.010","volume":"98","author":"P Zou","year":"2023","unstructured":"Zou P, Zhan Y, Xue R et al (2023) The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease. An Bras Dermatol 98:651\u2013655. https:\/\/doi.org\/10.1016\/j.abd.2022.07.010","journal-title":"An Bras Dermatol"},{"key":"666_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/01676830.2013.799705","volume":"32","author":"HS Mudhar","year":"2013","unstructured":"Mudhar HS, Duke R (2013) A case of orbital Rosai-Dorfman disease with IgG4 positive plasma cells. Orbit 32:315\u2013317. https:\/\/doi.org\/10.3109\/01676830.2013.799705","journal-title":"Orbit"},{"key":"666_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025165","volume":"100","author":"M Lee","year":"2021","unstructured":"Lee M, Ryu KH, Baek HJ et al (2021) Rosai-dorfman disease with infiltration of IgG4-bearing plasma cells presenting as laryngeal-nasal masses and cervical lymphadenopathy: a case report. Medicine (Baltimore) 100:e25165. https:\/\/doi.org\/10.1097\/MD.0000000000025165","journal-title":"Medicine (Baltimore)"},{"key":"666_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archoto.2011.52","volume":"137","author":"T-D Chen","year":"2011","unstructured":"Chen T-D, Lee L (2011) Rosai-dorfman disease presenting in the parotid gland with features of IgG4-related sclerosing disease. Arch Otolaryngol Head Neck Surg 137:705\u2013708. https:\/\/doi.org\/10.1001\/archoto.2011.52","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"666_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12890-019-0847-1","volume":"19","author":"P Gianella","year":"2019","unstructured":"Gianella P, Dulguerov N, Arnoux G et al (2019) Thyroid Rosai-Dorfman disease with infiltration of IgG4-bearing plasma cells associated with multiple small pulmonary cysts. BMC Pulm Med 19:83. https:\/\/doi.org\/10.1186\/s12890-019-0847-1","journal-title":"BMC Pulm Med"},{"key":"666_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2559.2010.03519.x","volume":"56","author":"SS Roberts","year":"2010","unstructured":"Roberts SS, Attanoos RL (2010) IgG4+ Rosai-dorfman disease of the lung. Histopathology 56:662\u2013664. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03519.x","journal-title":"Histopathology"},{"key":"666_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1513\/AnnalsATS.201510-703BC","volume":"13","author":"ST Apperley","year":"2016","unstructured":"Apperley ST, Hyjek EM, Musani R, Thenganatt J (2016) Intrathoracic Rosai Dorfman disease with focal aggregates of IgG4-bearing plasma cells. Case report and literature review. Ann Am Thorac Soc 13:666\u2013670. https:\/\/doi.org\/10.1513\/AnnalsATS.201510-703BC","journal-title":"Ann Am Thorac Soc"},{"key":"666_CR41","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2169\/internalmedicine.55.6749","volume":"55","author":"A Ichiki","year":"2016","unstructured":"Ichiki A, Hashimoto N, Ueda T et al (2016) Igg4-related disease with bone marrow involvement. Intern Med 55:2295\u20132299. https:\/\/doi.org\/10.2169\/internalmedicine.55.6749","journal-title":"Intern Med"},{"key":"666_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5114\/fn.2021.112565","volume":"59","author":"C Zhou","year":"2021","unstructured":"Zhou C, Ren H, Hong L et al (2021) Clinicopathological characteristics of multiple intracranial Rosai-Dorfman disease with increased IgG4-positive plasma cells: a report of two cases. Folia Neuropathol 59:409\u2013418. https:\/\/doi.org\/10.5114\/fn.2021.112565","journal-title":"Folia Neuropathol"},{"key":"666_CR43","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2169\/internalmedicine.8046-21","volume":"61","author":"S Kurahashi","year":"2022","unstructured":"Kurahashi S, Toda N, Fujita M et al (2022) Acute tubulointerstitial nephritis in Rosai-Dorfman disease mimicking IgG4-related disease. Intern Med 61:1027\u20131032. https:\/\/doi.org\/10.2169\/internalmedicine.8046-21","journal-title":"Intern Med"},{"key":"666_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.12932\/AP0862","volume":"36","author":"M Liu","year":"2018","unstructured":"Liu M, Li X, Li Y et al (2018) Rosai-dorfman disease with features of IgG4-related disease in the breast: cases report and literature review. Asian Pac J Allergy Immunol 36:51\u201357. https:\/\/doi.org\/10.12932\/AP0862","journal-title":"Asian Pac J Allergy Immunol"},{"key":"666_CR45","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1097\/PAS.0000000000001334","volume":"43","author":"J Tracht","year":"2019","unstructured":"Tracht J, Reid MD, Xue Y et al (2019) Rosai-dorfman disease of the pancreas shows significant histologic overlap with IgG4-related disease. Am J Surg Pathol 43:1536\u20131546. https:\/\/doi.org\/10.1097\/PAS.0000000000001334","journal-title":"Am J Surg Pathol"},{"key":"666_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8814871","volume":"2020","author":"JJ Poldemann","year":"2020","unstructured":"Poldemann JJ, Hinrichs BH, Makramalla A (2020) Unique presentation of Rosai-Dorfman disease as concomitant appendiceal and rectal masses with IgG4-positive plasma cells diagnosed by core needle biopsy. Case Rep Oncol Med 2020:8814871. https:\/\/doi.org\/10.1155\/2020\/8814871","journal-title":"Case Rep Oncol Med"},{"key":"666_CR47","doi-asserted-by":"publisher","first-page":"2050313X2311648","DOI":"10.1177\/2050313X231164864","volume":"11","author":"P Liu","year":"2023","unstructured":"Liu P, Lv P, Zhu M, Liu J (2023) A report of Rosai-Dorfman disease with systemic multiple lymphadenopathy and high IgG4 plasma cell infiltration. SAGE Open Med Case Rep 11:2050313X231164864. https:\/\/doi.org\/10.1177\/2050313X231164864","journal-title":"SAGE Open Med Case Rep"},{"key":"666_CR48","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/hematology.2024000584","volume":"2024","author":"LYC Chen","year":"2024","unstructured":"Chen LYC (2024) IgG4-related disease for the hematologist. Hematol Am Soc Hematol Educ Program 2024:594\u2013603. https:\/\/doi.org\/10.1182\/hematology.2024000584","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"666_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000432","volume":"3","author":"T Sasaki","year":"2017","unstructured":"Sasaki T, Akiyama M, Kaneko Y et al (2017) Distinct features distinguishing IgG4-related disease from multicentric Castleman\u2019s disease. RMD Open 3:e000432. https:\/\/doi.org\/10.1136\/rmdopen-2017-000432","journal-title":"RMD Open"},{"key":"666_CR50","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/rheumatology\/keab634","volume":"61","author":"T Sasaki","year":"2022","unstructured":"Sasaki T, Akiyama M, Kaneko Y, Takeuchi T (2022) Immunoglobulin G4-related disease and idiopathic multicentric Castleman\u2019s disease: confusable immune-mediated disorders. Rheumatology (Oxford) 61:490\u2013501. https:\/\/doi.org\/10.1093\/rheumatology\/keab634","journal-title":"Rheumatology (Oxford)"},{"key":"666_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.19037","volume":"60","author":"Y Han","year":"2020","unstructured":"Han Y, Igawa T, Ogino K et al (2020) Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease. J Clin Exp Hematop 60:1\u20136. https:\/\/doi.org\/10.3960\/jslrt.19037","journal-title":"J Clin Exp Hematop"},{"key":"666_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/jpm10040269","volume":"10","author":"MF Nishimura","year":"2020","unstructured":"Nishimura MF, Igawa T, Gion Y et al (2020) Pulmonary manifestations of plasma cell type idiopathic multicentric castleman disease: a clinicopathological study in comparison with IgG4-related disease. J Pers Med 10:269. https:\/\/doi.org\/10.3390\/jpm10040269","journal-title":"J Pers Med"},{"key":"666_CR53","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.18632\/oncotarget.24068","volume":"9","author":"K Otani","year":"2018","unstructured":"Otani K, Inoue D, Fujikura K et al (2018) Idiopathic multicentric Castleman\u2019s disease: a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 9:6691\u20136706. https:\/\/doi.org\/10.18632\/oncotarget.24068","journal-title":"Oncotarget"},{"key":"666_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152563","volume":"215","author":"N Kurose","year":"2019","unstructured":"Kurose N, Guo X, Shioya A et al (2019) The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome. Pathol Res Pract 215:152563. https:\/\/doi.org\/10.1016\/j.prp.2019.152563","journal-title":"Pathol Res Pract"},{"key":"666_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00795-016-0145-4","volume":"50","author":"A Manabe","year":"2017","unstructured":"Manabe A, Igawa T, Takeuchi M et al (2017) Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease. Med Mol Morphol 50:34\u201341. https:\/\/doi.org\/10.1007\/s00795-016-0145-4","journal-title":"Med Mol Morphol"},{"key":"666_CR56","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00380-018-1203-8","volume":"33","author":"S Kasashima","year":"2018","unstructured":"Kasashima S, Kawashima A, Kasashima F et al (2018) Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 33:1471\u20131481. https:\/\/doi.org\/10.1007\/s00380-018-1203-8","journal-title":"Heart Vessels"},{"key":"666_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/pin.12932","volume":"70","author":"A Satou","year":"2020","unstructured":"Satou A, Notohara K, Zen Y et al (2020) Clinicopathological differential diagnosis of IgG4-related disease: a historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int 70:391\u2013402. https:\/\/doi.org\/10.1111\/pin.12932","journal-title":"Pathol Int"},{"key":"666_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/pin.13185","volume":"72","author":"A Nishikori","year":"2022","unstructured":"Nishikori A, Nishimura MF, Nishimura Y et al (2022) Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease. Pathol Int 72:43\u201352. https:\/\/doi.org\/10.1111\/pin.13185","journal-title":"Pathol Int"},{"key":"666_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ijlh.14395","volume":"47","author":"F Alnoor","year":"2025","unstructured":"Alnoor F, Rangel A, Luo M et al (2025) Unicentric castleman disease: updates and novel insights into spindle cell proliferations and aggressive forms of a localized disease. Int J Lab Hematol 47:26\u201335. https:\/\/doi.org\/10.1111\/ijlh.14395","journal-title":"Int J Lab Hematol"},{"key":"666_CR60","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8\u2013negative\/idiopathic multicentric Castleman disease. Blood 129:1646\u20131657. https:\/\/doi.org\/10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"key":"666_CR61","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/jgh.15809","volume":"37","author":"K Sumimoto","year":"2022","unstructured":"Sumimoto K, Uchida K, Ikeura T et al (2022) Nationwide epidemiological survey of immunoglobulin G4\u2010related disease with malignancy in Japan. J Gastroenterol Hepatol 37:1022\u20131033. https:\/\/doi.org\/10.1111\/jgh.15809","journal-title":"J Gastroenterol Hepatol"},{"key":"666_CR62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00428-017-2286-9","volume":"472","author":"JR Bledsoe","year":"2018","unstructured":"Bledsoe JR, Wallace ZS, Stone JH et al (2018) Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch 472:839\u2013852. https:\/\/doi.org\/10.1007\/s00428-017-2286-9","journal-title":"Virchows Arch"},{"key":"666_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/AJCP\/AQX067","volume":"148","author":"JR Bledsoe","year":"2017","unstructured":"Bledsoe JR, Wallace ZS, Deshpande V et al (2017) Atypical IgG4+ plasmacytic proliferations and lymphomas: characterization of 11 cases. Am J Clin Pathol 148:215\u2013235. https:\/\/doi.org\/10.1093\/AJCP\/AQX067","journal-title":"Am J Clin Pathol"},{"key":"666_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/pin.13251","volume":"72","author":"Y Nishimura","year":"2022","unstructured":"Nishimura Y, Wien EA, Nishimura MF et al (2022) Clinical characteristics and outcomes of IgG4-positive marginal zone lymphoma: systematic scoping review. Pathol Int 72:361\u2013370. https:\/\/doi.org\/10.1111\/pin.13251","journal-title":"Pathol Int"},{"key":"666_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/modpathol.2010.206","volume":"24","author":"G Venkataraman","year":"2011","unstructured":"Venkataraman G, Rizzo KA, Chavez JJ et al (2011) Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 24:355\u2013366. https:\/\/doi.org\/10.1038\/modpathol.2010.206","journal-title":"Mod Pathol"},{"key":"666_CR66","doi-asserted-by":"publisher","first-page":"43052","DOI":"10.18632\/oncotarget.9678","volume":"7","author":"KA Ganapathi","year":"2016","unstructured":"Ganapathi KA, Jobanputra V, Iwamoto F et al (2016) The genetic landscape of dural marginal zone lymphomas. Oncotarget 7:43052\u201343061. https:\/\/doi.org\/10.18632\/oncotarget.9678","journal-title":"Oncotarget"},{"key":"666_CR67","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","volume":"26","author":"I Brenner","year":"2013","unstructured":"Brenner I, Roth S, Puppe B et al (2013) Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol 26:1568\u20131576. https:\/\/doi.org\/10.1038\/modpathol.2013.106","journal-title":"Mod Pathol"},{"key":"666_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/modpathol.2013.159","volume":"27","author":"JT Geyer","year":"2014","unstructured":"Geyer JT, Niesvizky R, Jayabalan DS et al (2014) IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol 27:375\u2013381. https:\/\/doi.org\/10.1038\/modpathol.2013.159","journal-title":"Mod Pathol"},{"key":"666_CR69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/pin.12968","volume":"70","author":"A Ito","year":"2020","unstructured":"Ito A, Yamauchi T, Nakano A et al (2020) IgG4 plasma cell myeloma: clinicopathological characteristics and diagnosis. Pathol Int 70:551\u2013556. https:\/\/doi.org\/10.1111\/pin.12968","journal-title":"Pathol Int"},{"key":"666_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/16078454.2020.1815130","volume":"25","author":"DTV Gauiran","year":"2020","unstructured":"Gauiran DTV, Marcon KM, DeMarco ML et al (2020) IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Hematology 25:335\u2013340. https:\/\/doi.org\/10.1080\/16078454.2020.1815130","journal-title":"Hematology"},{"key":"666_CR71","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2169\/internalmedicine.3839-19","volume":"59","author":"M Funada","year":"2020","unstructured":"Funada M, Nakano K, Miyata H et al (2020) IgG4-type multiple myeloma with diffuse enlargement of the thyroid requiring differentiation from IgG4-related disease. Intern Med 59:711\u2013714. https:\/\/doi.org\/10.2169\/internalmedicine.3839-19","journal-title":"Intern Med"},{"key":"666_CR72","doi-asserted-by":"publisher","first-page":"100379","DOI":"10.1016\/j.lrr.2023.100379","volume":"20","author":"A Bhalla","year":"2023","unstructured":"Bhalla A, Liu Q, Fang Y, Lefkowitch JH (2023) IgG4 plasma cell neoplasm in liver transplant biopsy masquerading as rejection. Leuk Res Rep 20:100379. https:\/\/doi.org\/10.1016\/j.lrr.2023.100379","journal-title":"Leuk Res Rep"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00666-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00666-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00666-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:21:58Z","timestamp":1763605318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00666-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00666-2","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}